Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CareDx, Inc. - Common Stock
(NQ:
CDNA
)
67.15
+0.92 (+1.39%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CareDx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results
January 13, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
From
CareDx, Inc.
Via
Business Wire
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) and CareDx Collaborate to Enhance TCB008 Cell Therapy Development for AML
December 11, 2024
Via
Investor Brand Network
CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
December 11, 2024
From
CareDx, Inc.
Via
Business Wire
A Closer Look at 5 Analyst Recommendations For CareDx
↗
October 22, 2024
Via
Benzinga
5 Analysts Assess CareDx: What You Need To Know
↗
October 16, 2024
Via
Benzinga
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
↗
November 26, 2024
Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.
Via
Benzinga
Topics
Artificial Intelligence
CareDx to Participate in Upcoming Investor Conferences
November 12, 2024
From
CareDx, Inc.
Via
Business Wire
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
↗
November 08, 2024
A Fed rate cut and a slew of big earnings reports filled out a busy week.
Via
Investor's Business Daily
Topics
Economy
Government
What 4 Analyst Ratings Have To Say About CareDx
↗
August 19, 2024
Via
Benzinga
CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
November 04, 2024
From
CareDx, Inc.
Via
Business Wire
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
↗
October 31, 2024
The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings.
Via
Benzinga
Topics
ETFs
Stocks
CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology
October 23, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting
October 21, 2024
From
CareDx, Inc.
Via
Business Wire
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
↗
October 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 15, 2024
Via
Benzinga
Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views
↗
October 15, 2024
Via
Benzinga
CareDx, JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
October 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 15, 2024
Via
Benzinga
CareDx Reports Preliminary Financial Results for Third Quarter 2024
October 15, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 11, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Appoints Jing Huang Chief Data and AI Officer
October 09, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Host Investor Day on October 15, 2024
October 08, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing
October 08, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 13, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 13, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer
September 12, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing
August 16, 2024
From
CareDx, Inc.
Via
Business Wire
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
↗
August 01, 2024
Via
Benzinga
CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance
July 31, 2024
From
CareDx, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
